Electrophoresis of BRCA1 oncosuppressor.

  • Authors:
    • D Bernard-Gallon
    • F De Oliveira
    • D Favy
    • C Hizel
    • J C Maurizis
    • P Rio
    • Y J Bignon
  • View Affiliations

  • Published online on: July 1, 1998     https://doi.org/10.3892/or.5.4.995
  • Pages: 995-1002
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

BRCA1 is a familial breast and ovarian cancer susceptibility gene and encodes proteins that function as tumor suppressors in human breast cancer cells. To elucidate the biological function of BRCA1, knowledge of cellular localization is needed. This can be achieved by using specific antibodies, so in a first step, we characterized by Western blot analysis the rabbit polyclonal antibodies (K-18) and (D-20) raised against the amino-terminus of human BRCA1 protein, and the polyclonal antibodies (C-20) and (I-20) raised against the carboxy terminus of human BRCA1 protein. The 220-kDa band corresponding to BRCA1 protein was recognized by the four tested antibodies in two mammary carcinoma cell lines (HBL100 and MCF7).

Related Articles

Journal Cover

Jul-Aug 1998
Volume 5 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bernard-Gallon D, De Oliveira F, Favy D, Hizel C, Maurizis J, Rio P and Bignon Y: Electrophoresis of BRCA1 oncosuppressor.. Oncol Rep 5: 995-1002, 1998.
APA
Bernard-Gallon, D., De Oliveira, F., Favy, D., Hizel, C., Maurizis, J., Rio, P., & Bignon, Y. (1998). Electrophoresis of BRCA1 oncosuppressor.. Oncology Reports, 5, 995-1002. https://doi.org/10.3892/or.5.4.995
MLA
Bernard-Gallon, D., De Oliveira, F., Favy, D., Hizel, C., Maurizis, J., Rio, P., Bignon, Y."Electrophoresis of BRCA1 oncosuppressor.". Oncology Reports 5.4 (1998): 995-1002.
Chicago
Bernard-Gallon, D., De Oliveira, F., Favy, D., Hizel, C., Maurizis, J., Rio, P., Bignon, Y."Electrophoresis of BRCA1 oncosuppressor.". Oncology Reports 5, no. 4 (1998): 995-1002. https://doi.org/10.3892/or.5.4.995